Validation of the Totaled Health Risks in Vascular Events (THRIVE) Score for Outcome Prediction in Endovascular Stroke Treatment
- 29 August 2012
- journal article
- research article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 9 (1) , 32-39
Abstract
Background: We recently developed the Totaled Health Risks In Vascular Events (THRIVE) score to predict outcomes after endovascular stroke treatment. The THRIVE score, which incorporates age, National Institutes of Health Stroke Scale score, and three medical comorbidities (hypertension, diabetes mellitus, and atrial fibrillation), was developed using data from the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Aims: We set out to perform external validation of the THRIVE score using data from the largest registry of endovascular stroke treatment performed to date, the Merci Registry. Methods: We compared the performance of the THRIVE score in two different data sets: the development cohort (the MERCI and Multi MERCI trials, n = 305) and a validation cohort (the Merci Registry, a prospective multicenter registry of patients undergoing endovascular stroke treatment, n = 1000). We examined the predictive utility of the THRIVE score across the range of clinical outcomes and used receiver–operator characteristics curve analysis to compare score performance in the two data sets. Results: The THRIVE score predicted good outcome, death, and the full range of the modified Rankin Scale in a similar fashion between the MERCI trials and the Merci Registry. Receiver–operator characteristics curve comparisons showed no statistically significant difference in the performance of the THRIVE score between the two data sets: for good outcome, the receiver–operator characteristics area under the curve was 0.293 for the MERCI trials and 0.266 for the Merci Registry ( P = 0.47) and for death, the receiver–operator characteristics area under the curve was 0.692 for the MERCI trials and 0.717 for the Merci Registry ( P = 0.48). The THRIVE score and vessel recanalization were also found to be independent and unrelated predictors of clinical outcome. Conclusions: The THRIVE score reliably predicts outcomes after endovascular stroke treatment and may be useful as a clinical prognostic tool and to perform severity adjustments in stroke clinical research.Keywords
This publication has 15 references indexed in Scilit:
- Patient Outcomes With Endovascular Embolectomy Therapy for Acute Ischemic StrokeStroke, 2011
- Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events ScoreAmerican Journal of Neuroradiology, 2010
- Predictors of Good Clinical Outcomes, Mortality, and Successful Revascularization in Patients With Acute Ischemic Stroke Undergoing ThrombectomyStroke, 2009
- The Penumbra Pivotal Stroke TrialStroke, 2009
- Thrombus Burden Is Associated With Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic StrokeStroke, 2008
- Validation of the Charlson Comorbidity Index for Predicting Functional Outcome of StrokeArchives of Physical Medicine and Rehabilitation, 2008
- Mechanical Thrombectomy for Acute Ischemic StrokeStroke, 2008
- Mechanical Thrombectomy of Intracranial Internal Carotid OcclusionStroke, 2007
- Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic StrokeStroke, 2005
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999